Blueprint Medicines Corp - Company Profile
Powered by 
All the sales intelligence you need on Blueprint Medicines Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Blueprint Medicines Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Blueprint Medicines Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Blueprint Medicines Corp patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230391780A1 | Application | Compositions and methods for treating kit- and pdgfra-mediated diseases | A61P35/00; C07D487/04 | December 07, 2023 |
| EP4285996A2 | Application | Inhibitoren der activin-rezeptor-like-kinase | A61K31/5025; A61K31/5377; A61K31/5383; A61P19/00; A61P25/00; A61P35/00; A61P43/00; C07D487/04; C07D519/00 | December 06, 2023 |
| FI3856341T3 | Grant | Crystalline forms of (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)pyrrolo[2,1-F][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making | A61P17/00; A61P35/00; A61P35/02; C07B2200/13; C07D487/04 | November 30, 2023 |
| US11827642B2 | Grant | Compositions useful for treating disorders related to kit | A61K31/496; A61K31/53; A61K31/5377; A61K45/06; C07D401/14; C07D403/04; C07D403/14; C07D413/14; C07D417/14; C07D487/04 | November 28, 2023 |
| WO2023215431A1 | Application | Salt and crystal forms of an epidermal growth factor receptor inhibitor | A61P35/00; C07D403/12 | November 09, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer